EU/1/15/1023/004 |
5854B |
Farydak 15 mg tvrdé kapsuly |
cps dur 6x15 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1023/003 |
5853B |
Farydak 10 mg tvrdé kapsuly |
cps dur 24x10 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1023/002 |
5848B |
Farydak 10 mg tvrdé kapsuly |
cps dur 12x10 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1023/001 |
5846B |
Farydak 10 mg tvrdé kapsuly |
cps dur 6x10 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/12/753/017 |
2400B |
Signifor 60 mg prášok a disperzné prostredie na injek?nú suspenziu |
plv iul 3x1x60 mg + 1x2 ml (liek.inj.skl.+striek.inj.skl.napl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/016 |
2399B |
Signifor 60 mg prášok a disperzné prostredie na injek?nú suspenziu |
plv iul 1x60 mg + 1x2 ml (liek.inj.skl.+striek.inj.skl.napl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/015 |
2398B |
Signifor 40 mg prášok a disperzné prostredie na injek?nú suspenziu |
plv iul 3x1x40 mg + 1x2 ml (liek.inj.skl.+striek.inj.skl.napl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/014 |
2397B |
Signifor 40 mg prášok a disperzné prostredie na injek?nú suspenziu |
plv iul 1x40 mg + 1x2 ml (liek.inj.skl.+striek.inj.skl.napl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/013 |
2396B |
Signifor 20 mg prášok a disperzné prostredie na injek?nú suspenziu |
plv iul 1x20 mg + 1x2 ml (liek.inj.skl.+striek.inj.skl.napl.) |
NEH-IE |
24.04.2017 |
EU/1/11/710/015 |
1604B |
Votubia 5 mg dispergovate?né tablety |
tbl dsp 100x5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/014 |
1603B |
Votubia 5 mg dispergovate?né tablety |
tbl dsp 30x5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/013 |
1602B |
Votubia 3 mg dispergovate?né tablety |
tbl dsp 100x3 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/012 |
1601B |
Votubia 3 mg dispergovate?né tablety |
tbl dsp 30x3 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/011 |
1600B |
Votubia 2 mg dispergovate?né tablety |
tbl dsp 100x2 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/010 |
1599B |
Votubia 2 mg dispergovate?né tablety |
tbl dsp 30x2 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/009 |
1598B |
Votubia 2 mg dispergovate?né tablety |
tbl dsp 10x2 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/008 |
8527A |
Votubia 10 mg tablety |
tbl 10x10 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/12/753/012 |
1223A |
Signifor 0,9 mg injek?ný roztok |
sol inj 60x1 ml/0,9 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/011 |
1222A |
Signifor 0,9 mg injek?ný roztok |
sol inj 30x1 ml/0,9 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/010 |
1221A |
Signifor 0,9 mg injek?ný roztok |
sol inj 18x1 ml/0,9 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/009 |
1220A |
Signifor 0,9 mg injek?ný roztok |
sol inj 6x1 ml/0,9 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/008 |
1219A |
Signifor 0,6 mg injek?ný roztok |
sol inj 60x1 ml/0,6 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/007 |
1218A |
Signifor 0,6 mg injek?ný roztok |
sol inj 30x1 ml/0,6 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/006 |
1217A |
Signifor 0,6 mg injek?ný roztok |
sol inj 18x1 ml/0,6 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/005 |
1216A |
Signifor 0,6 mg injek?ný roztok |
sol inj 6x1 ml/0,6 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/004 |
1215A |
Signifor 0,3 mg injek?ný roztok |
sol inj 60x1 ml/0,3 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/003 |
1214A |
Signifor 0,3 mg injek?ný roztok |
sol inj 30x1ml/0,3 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/002 |
1213A |
Signifor 0,3 mg injek?ný roztok |
sol inj 18x1 ml/0,3 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/12/753/001 |
1212A |
Signifor 0,3 mg injek?ný roztok |
sol inj 6x1 ml/0,3 mg (amp.skl.) |
NEH-IE |
24.04.2017 |
EU/1/07/422/012 |
11647 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 120(3x40)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/011 |
11646 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 40x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/010 |
11645 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 120(3x40)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/009 |
11644 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 40x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/11/710/007 |
10970 |
Votubia 10 mg tablety |
tbl 100x10 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/006 |
10968 |
Votubia 10 mg tablety |
tbl 30x10 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/005 |
10966 |
Votubia 5 mg tablety |
tbl 100x5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/004 |
10958 |
Votubia 5 mg tablety |
tbl 30x5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/003 |
10957 |
Votubia 2,5 mg tablety |
tbl 100x2,5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/002 |
10956 |
Votubia 2,5 mg tablety |
tbl 30x2,5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/11/710/001 |
10952 |
Votubia 2,5 mg tablety |
tbl 10x2,5 mg (blis.PA/Al/PVC/Al) |
NEH-IE |
16.11.2020 |
EU/1/10/652/003 |
10778 |
TOBI Podhaler 28 mg inhala?ný prášok v tvrdých kapsulách |
plv icd 448(8x56)x28 mg (blis.PVC/PA/Al/PVC-PET/Al + 10 inhalátorov) |
NEH-IE |
|
EU/1/10/652/002 |
10777 |
TOBI Podhaler 28 mg inhala?ný prášok v tvrdých kapsulách |
plv icd 224(4x56)x28 mg (blis.PVC/PA/Al/PVC-PET/Al + 5 inhalátorov) |
NEH-IE |
|
EU/1/10/652/001 |
10776 |
TOBI Podhaler 28 mg inhala?ný prášok v tvrdých kapsulách |
plv icd 56x28 mg (blis.PVC/PA/Al/PVC-PET/Al +1 inhalátor) |
NEH-IE |
|
EU/1/07/422/008 |
09720 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/007 |
09719 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 28x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/10/625/003 |
06207 |
Arzerra 1000 mg infúzny koncentrát |
con inf 1x50 ml/1000 mg (liek.inj.skl.) |
NEH-IE |
21.04.2016 |
EU/1/07/422/006 |
03850 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 112(4x28)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/005 |
03849 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 28x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/10/625/001 |
89034 |
Arzerra 100 mg infúzny koncentrát |
con inf 3x5 ml/100 mg (liek.inj.skl.) |
NEH-IE |
21.04.2016 |
EU/1/07/422/004 |
46944 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PA/Al/PVC/Al) púzdro |
NEH-IE |
|